
Jury Finds for C.R. Bard in PowerPort Case
A federal jury in Arizona sided with the medical device maker in the third bellwether trial of the multidistrict PowerPort litigation.
Diseases in Phoenix runs on diagnosis, treatment breakthroughs and public health impact, and coverage here follows all of it. Reporting includes the latest medical research, disease management and safety alerts.

A federal jury in Arizona sided with the medical device maker in the third bellwether trial of the multidistrict PowerPort litigation.
Live Poll
Should the FDA fast-track approval for experimental cell therapies to treat chronic heart failure?
The medical technology firm will share trial design details at the Heart Failure Society of America meeting.

Researchers at the Translational Genomics Research Institute tested AlphaFold3 on immune complexes linked to tuberculosis, a step toward predicting which antigens T cells recognize.

The company will share Phase 1/2 clinical trial findings on November 7, 2026, at a major cancer immunotherapy meeting.

Live Poll
Do you trust artificial intelligence to improve the quality of your medical diagnosis and care?
New AI integration strategies for managing chronic obstructive pulmonary disease were highlighted at the CHEST 2026 Annual Meeting.

The National Institutes of Health funding supports two additional years of research for the national ALL ALS Consortium.
Phoenix reporting spans medical diagnosis and treatment, public health alerts, local clinical trial results and health management. Coverage reaches across the city and the communities around it. Seasonal factors such as heat and air quality influence how certain conditions affect the area throughout the year. New research findings and updates to public health guidelines appear most often in the current reports.